Portal de investigación
ESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, PARA EVALUAR LA SEGURIDAD Y EFICACIA DE TENOFOVIR ALAFENAMIDA 25 MG UNA VEZ AL DÍA FRENTE A FUMARATO DE TENOFOVIR DISOPROXIL 300 MG UNA VEZ AL DÍA PARA EL TRATAMIENTO DE LA HEPATITIS B CRÓNICA HBEAG-POSITIVO.
Datos básicos
- Protocolo:
- GS-US-320-0110
- EUDRACT:
- 2013-000636-10
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2014
- Año de finalización:
- 2015
Objetivos del proyecto
Observaciones: Estado Comité: CENTRO CERRADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Salmeron, J.; (...); Prieto, M.
Article. 10.1016/S0168-8278(14)61356-8. 2014
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
Rodriguez Novoa, Sonia; (...); Castro, Angeles
Article. 2014
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
Medina-Caliz, I.; (...); Andrade, R. J.
Article. 10.1016/S0168-8278(14)60472-4. 2014
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Avances en el tratamiento de la hepatitis C.
Vinaixa C, Aguilera V, Berenguer M
Abstract of Published Item. 10.1016/j.medcli.2013.01.041. 2013
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
CHARACTERIZATION OF HBsAg LOSS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS/TIDE ANALOGS (NUCS): A RETROSPECTIVE MULTICENTER STUDY (HEBESAS)
Suarez, E.; (...); Fuentes, J.
Article. 10.1016/S0168-8278(15)30854-0. 2015
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids
Robles-Diaz M; (...); SLatinDILI Network
Article. 10.1111/apt.13023. 2015
DISTINGUISHING DRUG INDUCED AUTOIMMUNE HEPATITIS FROM IDIOPATIC AUTOIMMUNE HEPATITIS
Ortega-Alonso, A.; (...); Lucena, M. I.
Article. 10.1016/S0168-8278(15)31294-0. 2015
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT
FERNANDEZ, C.; (...); Salmeron, J.
Article. 10.1016/S0168-8278(14)61360-X. 2014
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Buti M; (...); Gila A
Article. 10.1097/MEG.0000000000000195. 2015
Estrategias para evitar la recidiva viral B despues del trasplante hepatico.
Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
FIRST REAL CLINICAL PRACTICE DATA IN SPAIN ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR IN POST-TRANSPLANT HCV RECURRENCE: THE HepatiC REGISTRY EXPERIENCE
Prieto, M.; (...); Forns, X.
Article. 10.1016/S0168-8278(15)30988-0. 2015
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin
Buti M; (...); Esteban R
Article. 10.1111/tid.12360. 2015
Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies
Buti, Maria; (...); Rodriguez-Frias, Francisco
Article. 2014
IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY
Cerini, F.; (...); Garcia-Pagan, J. C.
Article. 10.1016/S0168-8278(14)60019-2. 2014
Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease
Blé M; (...); Berenguer M
Article. 10.1002/lt.23756. 2014
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Progress in hepatitis C treatment
Vinaixa, Carmen, Aguilera, Victoria, Berenguer, Marina
Review. 2013
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose
Meeting Abstract. 2014
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Forns X; (...); Habersetzer F
Article. 10.1002/hep.27681. 2015
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Buti, M.; (...); Esteban, R.
Article. 10.1016/S0168-8278(14)61200-9. 2014
TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL
Jorquera, F.; (...); Rodriguez, M.
Article. 10.1016/S0168-8278(14)61201-0. 2014
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Roman A; (...); Ussetti P
Article. 10.1016/j.trre.2014.01.001. 2014
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Briceño J; (...); de la Mata M
Article. 10.1016/j.jhep.2014.05.039. 2014
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium
Article. 10.1053/j.gastro.2014.03.050. 2014